- 21 September
-
On September 11–17, 2026, Ekaterinburg hosted the International Youth Festival, a large-scale event that brought together 10,000 young leaders from 191 countries. At the festival running under the motto «Follow Your Dream,» the Medsintez Plant presented its exhibition, showcasing the achievements of the Ural pharmaceutical industry in the field of import substitution.
- 18 September
-
The updated clinical guidelines for treatment of ARVI in children took effect on September 2, 2026. The document was developed by leading experts from the Union of Pediatricians of Russia, the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC), and the Russian Society of Emergency Medical Care and approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation. It fundamentally shifts therapeutic approaches toward enhanced safety and minimal drug burden.
- 14 September
-
On September 3–4, 2026, Nizhny Novgorod hosted the 2nd Regional Endocrinological Congress: Challenges and Prospects of the Volga Region, with the active participation of the Medsintez Plant. As a strategic company, Medsintez Plant has been ensuring Russia's pharmaceutical security for 25 years. Company's exhibition booth showcased a range of hormonal medications for treatment of type 1 and type 2 diabetes, as well as drugs for infertility treatment through the IVF method.
- 04 September
-
More than twenty years ago, the Regiony Rossii (Regions of Russia, RR) magazine witnessed the birth of an innovative pharmaceutical production facility in Novouralsk, which had no analogues in the country. Today, the Medsintez Plant is a strategic asset in terms of national pharmaceutical security, a recognized industry leader, a National Champion, and a winner of prestigious awards. The secret behind the success of the Ural school of pharmaceuticals and biotechnology is explored in this article by RR.
- Home
- Cluster members
- The State Autonomous Healthcare Institution of the Sverdlovsk Region «Sverdlovsk Regional Oncological Dispensary»
The State Autonomous Healthcare Institution of the Sverdlovsk Region «Sverdlovsk Regional Oncological Dispensary»
The State Autonomous Healthcare Institution of the Sverdlovsk Region «Sverdlovsk Regional Oncological Dispensary» is the leading medical center in the region providiry specialized high-tech healthcare assistance for the oncological patients at Sverdlovsk region.
The Sverdlovsk Regional Oncological Dispensary is the participant of the national project «Healthcare», the federal project «Fight against oncological diseases», the largest oncological clinic in the Middle Urals and the head institution of the oncological service of the Sverdlovsk region. All modern methods for the diagnostic and treatment of available on the base of the oncological center.
Every year, medical staff performs over 22 400 surgeries, 29 200 chemotherapy courses and 8 100 radiation therapy courses actually.
The potential of medicine grows. The issues of early diagnosis and treatment of malignant neoplasms are of particular interest. Sverdlovsk oncologists improve their knowledge and skills at all-Russian and international scientific forums, conferences, symposiums. Specialists of oncological dispensary teach general practicants in new methods of treating and diagnosing oncological diseases, and conduct classes for patients and their relatives.
The oncological dispensary aim is to make modern medical oncological care affordable and of high quality. The Sverdlovsk Regional Oncology Center is focused on the highest world standards.
The Sverdlovsk Regional Oncological Dispensary branches in Yekaterinburg, Branch №1 in the city of Nizhny Tagil and Branch №2 in the city of Kamensk-Uralsky.
